help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marx, S. J.
Right arrow Articles by Umiker, W. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marx, S. J.
Right arrow Articles by Umiker, W. O.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Breast Diseases
Hazardous Substances DB
*PARATHYROID HORMONE

Journal of Clinical Endocrinology & Metabolism, Vol 45, 1049-1052, Copyright © 1977 by Endocrine Society

ARTICLES

Benign breast dysplasia causing hypercalcemia

SJ Marx, RM Zusman and WO Umiker

An adolescent female had hypercalcemia and massive, bilateral breast enlargement. At neck and mediastinal explorations three parathyroid glands were removed and found to be histologically normal. Following bilateral mastectomy the hypercalcemia resolved within two days and did not recur during a six-year period of followup. Microscopic examination of the excised breast tissue revealed marked dysplasia but no cancer. Those findings suggest that benign, dysplastic breast tissue can release humoral mediators of hypercalcemia.




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1977 by The Endocrine Society